19 completed, 2 unknown. 21 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 21 | Completed 19, Unknown 2 |
Follow Meloxicam: new trials by email Literature Review of Meloxicam trials Research Report on Meloxicam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian coadministration of JP-1366 and aceclofenac, coadministration of JP-1366 and meloxicam, coadministration of JP-1366 and naproxen - Anti-Ulcer Agents | Phase 1 | Completed | Onconic Therapeutics Inc. | 88 | 2021-03-05 | 2022-06-30 |
| Drug-drug Interaction Between DWP14012 and Three Different Kinds of NSAIDs DWP14012, Celecoxib, Naproxen - Healthy Male Volunteers | Phase 1 | Unknown | Daewoong Pharmaceutical Co. LTD. | 110 | 2020-06-19 | 2020-07-29 |
| Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers Meloxicam - Healthy Volunteers | Phase 1 | Unknown | Beijing Tongren Hospital | 80 | 2019-12-16 | 2020-04-28 |
| A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets Meloxicam Capsule (Test), Meloxicam Tablet (Reference) - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 26 | 2018-10-05 | 2019-11-22 |
| On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility Ulipristal Acetate 30 MG Oral Tablet - Contraception | Phase 1 | Completed | Stanford University | 12 | 2018-03-15 | 2019-06-25 |
| Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition Reumoxicam® 15 mg tablets (PJSC "Farmak", Ukraine), Movalis 15 mg tablets ("Boehringer Ingelheim Ellas A.E.", Greece) - Pharmacokinetics | Phase 1 | Completed | Joint Stock Company "Farmak" | 24 | 2014-01-29 | 2021-11-18 |
| Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women Meloxicam 2.4 g, Meloxicam 3.0 g - Contraception, Bleeding Pattern | Phase 1 | Completed | Laboratorios Andromaco S.A. | 13 | 2013-01-15 | 2019-04-30 |
| Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult Volunteers Meloxicam capsule, Meloxicam tablet - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 6 | 2008-11-01 | 2014-07-08 |
| Aspirin Resistance in Systemic Lupus Erythematosus (SLE) aspirin and meloxicam - Systemic Lupus Erythematosus | Phase 1 | Completed | Vanderbilt University | 70 | 2005-04-01 | 2017-08-07 |
| Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition Meloxicam - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 28 | 2004-10-01 | 2010-07-13 |
| Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition Meloxicam - Healthy | Phase 1 | Completed | Dr. Reddy's Laboratories Limited | 28 | 2004-09-01 | 2010-07-13 |
| Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Meloxicam Tablets 15 mg, Mobic® Tablets 15 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 27 | 2004-08-01 | 2024-04-24 |
| Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg Meloxicam Tablets 15 mg, Mobic® Tablets 15 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 30 | 2004-08-01 | 2024-04-24 |
| Meloxicam 15 mg Tablets Under Fasting Conditions Meloxicam 15 mg Tablets, Mobic® 15 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 28 | 2004-02-01 | 2024-08-19 |
| Meloxicam 15 mg Tablets Under Non-Fasting Conditions Meloxicam 15 mg Tablets, Mobic® 15 mg Tablets - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 28 | 2004-02-01 | 2024-08-19 |
| Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and Females Meloxicam, Aspirin - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2002-07-01 | 2014-07-14 |
| Effect of Food on the Pharmacokinetics of Meloxicam in Healthy Volunteers Meloxicam, low dose, Meloxicam, medium dose, Meloxicam, high dose - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 24 | 2002-01-01 | 2014-07-08 |
| Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range Meloxicam - low dose, Meloxicam - medium dose, Meloxicam - high dose - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 24 | 2001-06-01 | 2014-07-08 |
| Study of Relative Bioavailability of Mobic Manufactured in China in Comparison With Mobic Manufactured in Germany in Chinese Healthy Volunteers Mobic, China, 7.5 mg, Mobic, Germany, 7.5 mg - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 20 | 2001-03-01 | 2014-07-08 |
| Pharmacokinetics and Tolerability of Meloxicam Injected Intramuscularly vs. Tablet in Healthy Subjects Meloxicam ampoule, Meloxicam tablet - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 12 | 1998-11-01 | 2014-07-08 |
Showing 20 of 21. Sign in to see all of them.
Lupus Erythematosus, Systemic (1)
Boehringer Ingelheim (8) · Dr. Reddy's Laboratories Limited (2) · Mylan Pharmaceuticals Inc (2) · Teva Pharmaceuticals USA (2) · Beijing Tongren Hospital (1) · Daewoong Pharmaceutical Co. LTD. (1) · Joint Stock Company "Farmak" (1) · Laboratorios Andromaco S.A. (1) · Onconic Therapeutics Inc. (1) · Stanford University (1) · Vanderbilt University (1)
Canada (4) · United States (4) · South Korea (2) · Chile (1) · China (1) · Russia (1)
Deepen M Patel, M.D., C.C.F.P. (2) · Dorian Williams, M.D. (2) · Paul Y. Tam, M.D. (2) · C M Stein, M.D. (1) · Jang In-Jin, MD, PhD (1) · Vlad Udovytskyi (1) · Xiuli Zhao, Ph.D. (1)
PMID 24022862, PMID 35470225, PMID 38700290
R01HL065082 (1)